93 related articles for article (PubMed ID: 7704845)
1. Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.
Priosoeryanto BP; Tateyama S; Yamaguchi R; Uchida K
Can J Vet Res; 1995 Jan; 59(1):67-9. PubMed ID: 7704845
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
3. The biological effects of five feline IFN-alpha subtypes.
Baldwin SL; Powell TD; Sellins KS; Radecki SV; Cohen JJ; Milhausen MJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):153-67. PubMed ID: 15135982
[TBL] [Abstract][Full Text] [Related]
4. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
5. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours.
Tateyama S; Priosoeryanto BP; Yamaguchi R; Uchida K; Ogiwara K; Suchiya AT
Res Vet Sci; 1995 Nov; 59(3):275-7. PubMed ID: 8588106
[TBL] [Abstract][Full Text] [Related]
6. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
7. Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1.
Siebeck N; Hurley DJ; Garcia M; Greene CE; Köstlin RG; Moore PA; Dietrich UM
Am J Vet Res; 2006 Aug; 67(8):1406-11. PubMed ID: 16881854
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant immunotherapy of feline fibrosarcoma with recombinant feline interferon-omega.
Hampel V; Schwarz B; Kempf C; Köstlin R; Schillinger U; Küchenhoff H; Fenske N; Brill T; Hirschberger J
J Vet Intern Med; 2007; 21(6):1340-6. PubMed ID: 18196745
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro.
Mochizuki M; Nakatani H; Yoshida M
Vet Microbiol; 1994 Mar; 39(1-2):145-52. PubMed ID: 7515537
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration.
Paltrinieri S; Crippa A; Comerio T; Angioletti A; Roccabianca P
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):68-74. PubMed ID: 17521745
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
12. [Antiproliferative activities of interferon-alpha].
Ishii K; Yoshida H; Yanagihara Y; Kiyonaga J; Shirahama T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1983-9. PubMed ID: 4051515
[TBL] [Abstract][Full Text] [Related]
13. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs.
Ishiwata K; Minagawa T; Kajimoto T
J Vet Med Sci; 1998 Aug; 60(8):911-7. PubMed ID: 9764403
[TBL] [Abstract][Full Text] [Related]
15.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
Front Vet Sci; 2019; 6():104. PubMed ID: 31024941
[No Abstract] [Full Text] [Related]
16. Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog.
Kuwabara M; Nariai Y; Horiuchi Y; Nakajima Y; Yamaguchi Y; Horioka E; Kawanabe M; Kubo T; Yukawa M; Sakai T
Microbiol Immunol; 2006; 50(8):637-41. PubMed ID: 16924149
[TBL] [Abstract][Full Text] [Related]
17. Receptors for recombinant feline interferon-omega in hemocytes of the Japanese pearl oyster Pinctada fucata martensii.
Miyazaki T; Taniguchi T; Hirayama J; Nozawa N
Dis Aquat Organ; 2002 Aug; 51(2):135-8. PubMed ID: 12363085
[TBL] [Abstract][Full Text] [Related]
18. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S
Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT; Regazzi E; Garau D; Akard L; Dugan M; Boswell HS; Rizzoli V; Carlo-Stella C
Cancer Res; 1999 Oct; 59(19):5047-53. PubMed ID: 10519422
[TBL] [Abstract][Full Text] [Related]
20. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
Moser M; Burns CC; Boomer S; Overbaugh J
Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]